# FDA Inspection 1130508 - Octapharma Plasma, Inc. - September 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a80a583e-b0a7-4327-90a2-3bed5eef5a36
Source feed: FDA_Inspections

> FDA Inspection 1130508 for Octapharma Plasma, Inc. on September 11, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1130508
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2020-09-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1047937 - 2018-03-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/42f4b398-de27-4348-9f40-912717597fb1)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/8b2fc5d5-18c1-40a7-8582-1355d3688b09

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d